EpiBiologics Presents First Data on c-Met Bispecific Antibody
28 Apr 2025 //
BUSINESSWIRE
EpiBiologics to Present Data on Protein Degradation Platform
04 Nov 2024 //
BUSINESSWIRE
EpiBiologics Protein Degrader Demonstrate Robust Preclinical Anti-tumor Activity
08 Apr 2024 //
BUSINESSWIRE
EpiBiologics Appoints Ann Lee-Karlon as CEO and President
20 Jul 2023 //
BUSINESSWIRE